STOCK TITAN

Bio-Key Intl Inc Stock Price, News & Analysis

BKYI Nasdaq

Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.

BIO-key International, Inc. (NASDAQ: BKYI) is an identity and access management (IAM) and biometric authentication company whose news flow centers on product innovation, strategic partnerships, investor communications, and capital markets activity. Press releases describe BIO-key as a biometric-centric, multi-factor IAM provider enabling phoneless, tokenless, passwordless, and phishing-resistant authentication for enterprise and large-scale identity deployments.

On this page, readers can follow updates on BIO-key’s participation in industry conferences and investor events, such as the Gartner Identity & Access Management Summit, the Africa Tech Festival, and the DealFlow Discovery investor conference. These announcements often highlight new passwordless capabilities, identity-bound biometric technologies, and demonstrations of the PortalGuard IAM platform.

Company news also covers strategic partnerships that extend BIO-key’s reach in key regions. Recent releases describe collaborations with SAVIS Group in Vietnam, VaporVM in the Middle East and Africa, and Cloud Distribution in Saudi Arabia. Through these relationships, BIO-key’s IAM and biometric solutions are integrated into broader cybersecurity and digital transformation offerings for enterprises, government agencies, and institutions.

Investors can track earnings-related communications and balance sheet updates through quarterly results announcements and associated investor calls. BIO-key’s news includes details on hardware launches such as the EcoID III fingerprint scanner, as well as disclosures about warrant exercise agreements and secured promissory notes that affect the company’s capital structure.

By monitoring the BKYI news feed, users can see how BIO-key positions its biometric and IAM technologies in sectors such as defense, finance, government, and education, and stay informed about material events reported in press releases that complement the company’s formal SEC filings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.3%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.29%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.77%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.06%
Tags
partnership
-
Rhea-AI Summary

BIO-key International (Nasdaq: BKYI) announced receiving a Notification Letter from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1), due to the failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The company filed a Notification of Late Filing on March 31, 2023, citing the need for more time to compile necessary financial information. The Notification Letter allows the company 60 days to submit a plan for compliance, potentially extending the deadline to October 16, 2023. The company's common stock remains listed on the Nasdaq Capital Market. BIO-key emphasizes its commitment to filing the Form 10-K as soon as possible to regain compliance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.96%
Tags
none
-
Rhea-AI Summary

BIO-key International (NASDAQ: BKYI) has announced the migration of three customers from on-premises deployments of PortalGuard to its PortalGuard IDaaS cloud platform. The new customers include Leon County Supervisor of Elections, Unity College, and Rockford University. This transition aims to enhance IT infrastructure by modernizing operations, increasing efficiency, and reducing costs while securing applications from cyber threats. The growing demand for cloud solutions highlights the need for better security in remote work environments. Mark Cochran, President of BIO-key, emphasized the advantages of cloud migration, including agility, scalability, and cost-effectiveness in managing IT resources.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
none
Rhea-AI Summary

BIO-key International (NASDAQ: BKYI) announced that Dayton Children's Hospital will expand its investment in biometric authentication by adding the PortalGuard IDaaS platform. This upgrade facilitates the migration from Epic Systems' legacy Hyperspace application to the new Hyperdrive interface, enhancing security and user experience without requiring re-enrollment. The migration is part of a deadline for all Epic customers to transition by November 2023. BIO-key's PortalGuard supports multiple authentication methods, enabling a streamlined login experience. The company has been a trusted partner of Dayton Children's since 2011, ensuring compliance with DEA regulations while providing a user-friendly solution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

BIO-key International, Inc. (BKYI) reported strong financial growth for Q4'22 and FY'22, with a revenue increase of 88% to $1.7M in Q4 and a 37% rise to $7.0M for the full year. The growth stemmed from increased software and service revenues, countered by lower hardware sales. The company expanded its customer base in higher education and government sectors and launched the Mobile Authenticator App in 2022. Despite a net loss of $10.2M for FY'22, BIO-key aims for profitability in 2023 through cost-reduction measures. The company expects record revenue in Q1'23, bolstered by a growing annual recurring revenue base.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.66%
Tags
conferences
-
Rhea-AI Summary

BIO-key International announced a strategic partnership with Ethnos IT Solutions, aiming to enhance cybersecurity through innovative Identity and Access Management (IAM) solutions across Africa. Ethnos, recognized as a leader in cybersecurity and compliance management, will help BIO-key expand its international presence. The collaboration includes participation in BIO-key’s Channel Alliance Partner program, facilitating new revenue streams through products like the PortalGuard IAM platform. The partnership is expected to leverage Ethnos's reputation and expertise, benefiting both companies in the growing African market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
partnership
Rhea-AI Summary

BIO-key International, Inc. (NASDAQ: BKYI) will host a conference call on March 31, 2023, at 10 a.m. ET to discuss its Q4 and full year results. The financial results will be released before the market opens that day. Mike DePasquale, Chairman & CEO, and Cecilia Welch, CFO, will lead the call and engage in a Q&A session with participants. The call can be accessed via a live audio link and will be available for replay for three months. BIO-key specializes in Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, managing millions of users and providing secure access to critical information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.62%
Tags
conferences

FAQ

What is the current stock price of Bio-Key Intl (BKYI)?

The current stock price of Bio-Key Intl (BKYI) is $5.24 as of May 8, 2026.

What is the market cap of Bio-Key Intl (BKYI)?

The market cap of Bio-Key Intl (BKYI) is approximately 5.8M.